Honest comparison
Amidra vs PeptidePal
Two peptide + GLP-1 trackers with different philosophies — one leans on a large in-app library and an AI advisor, the other on transparent, user-entered math. Here's an even-handed look.
| Amidra | PeptidePal | |
|---|---|---|
| Focus | Peptide + GLP-1 hybrid | Peptide + GLP-1 + TRT hybrid |
| Reconstitution calculator | Yes — formulas shown at each step, capacity warnings | Yes — live syringe illustration, over-capacity warning |
| Compound library | Plain-English explainers on the web, definitional only | Large in-app library with half-life & reference notes |
| Curated stacks | No — you build your own protocols | Yes — curated starter stacks |
| AI advisor | None, by design | Yes — AI Advisor (declines Rx dosing) |
| Minimum iOS | iOS 17+ | iOS 18+ |
| Free tier | First protocol, calculator, logging & rotation free | Free to start; subscription for protocols/analytics |
Where PeptidePal leads
- The commercial leader in the peptide-tracking category, with a large, established user base and a high review score.
- A deep in-app compound library — dozens of peptides with nicknames, half-life and reference notes.
- Curated protocol "stacks" you can start from, rather than building every protocol from scratch.
- A polished reconstitution calculator with a live syringe illustration and an over-capacity warning.
- An in-app AI Advisor for general questions (it declines to give prescription dosing).
Where Amidra takes a different approach
- No AI advisor layer at all — Amidra only converts the numbers you enter, and never estimates, suggests, or advises a dose.
- The reconstitution formulas stay visible at every step (concentration, draw volume, syringe units), so you can check the math by hand rather than trust a single output.
- Runs on iOS 17 and up, where PeptidePal currently requires iOS 18 — so it reaches slightly older devices.
- A free tier you can keep using for your first protocol indefinitely, with plain-English compound explainers on the open web rather than behind the app.
Which might fit you
If you want the largest ready-made compound library, curated stacks, and an AI assistant, PeptidePal is the more feature-dense option and the category's commercial leader. If you'd rather a lighter app that shows its math, adds no AI layer, and runs on iOS 17, Amidra is built around that transparency. Neither recommends a dose — both leave that to you and your clinician.
Common questions
Is Amidra affiliated with PeptidePal?
No. Amidra is an independent app and is not affiliated with, endorsed by, or connected to PeptidePal. PeptidePal is a trademark of its owner, referenced here only for factual comparison.
Which app has more compounds?
PeptidePal has the larger in-app compound library, with dozens of peptides and reference notes. Amidra keeps its compound explainers on the open web as plain-English, definitional pages rather than an in-app database.
Does Amidra have an AI advisor like PeptidePal?
No, and that is deliberate. Amidra has no AI layer — it converts the values you enter and never suggests or advises a dose, compound, or schedule.
Do either of these apps recommend doses?
No. Neither app recommends prescription dosing. Amidra only does arithmetic on the values you enter; every dose comes from you and your clinician.
Is Amidra a good PeptidePal alternative?
It depends what you want from a tracker. Amidra is a peptide + GLP-1 hybrid built around a transparent reconstitution calculator and values you enter yourself — it never suggests a dose. If that approach fits how you work, it is worth trying alongside PeptidePal; the table and the "where PeptidePal leads" section above lay out where each one is stronger so you can judge for yourself. Amidra is not affiliated with PeptidePal, and this page is a factual comparison, not a substitute for reading PeptidePal's own reviews.